Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Intellia Therapeutics Inc’s current trading price is -66.57% away from its 52-week high, while its distance from the 52-week low is 30.10%. The stock’s price range during this period has varied between $8.96 and $34.87. The company, active in the Healthcare sector, saw a trading volume of around 1.26 million for the day, considerably lower average daily volume of 2.87 million observed over the last three months.
Intellia Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $34.87 on 02/29/24, while the lowest price during the same period was $8.96 on 02/12/25.
How Financial Performance Impacts Market Capitalization
Intellia Therapeutics Inc (NTLA) has experienced a quarterly decline of -18.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.19B and boasts a workforce of 526 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.67, with a change in price of -6.83. Similarly, Intellia Therapeutics Inc recorded 2,846,231 in trading volume during the last 100 days, posting a change of -36.80%.
How NTLA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NTLA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.
NTLA Stock Stochastic Average
As of today, the raw stochastic average of Intellia Therapeutics Inc over the last 50 days is at 57.21%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 71.22%. Further, the company’s Stochastic %K and %D values for the last 20 days were 54.58% and 57.28%, respectively.
NTLA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -0.03%. However, over the past six months, we’ve seen a stronger performance of -50.56%. The price of NTLA fallen by 16.45% over the last 30 days. And in the last five days, it has fallen by -4.84%.
